SEELOS THERAPEUTICS, INC.

Profile

Company Names

SEELOS THERAPEUTICS, INC.
APRICUS BIOSCIENCES, INC.
NEXMED INC

Addresses

300 PARK AVENUE, 2ND FLOOR, NEW YORK, NY 10022

300 PARK AVENUE, 12TH FLOOR, NEW YORK, NY 10022

11975 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA 92130

6330 NANCY RIDGE DRIVE, SUITE 103, SAN DIEGO, CA 92121

Phone Numbers

(646) 293-2100
(646) 998-6475
(858) 222-8041
(858) 450-0048

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$13,644,106.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2024-07-11 
$0.00 
$1,146,481.00 
$1,146,481.00 
 
8
2024-05-21 
$0.00 
$2,042,954.00 
$2,042,954.00 
 
7
2024-01-30 
$0.00 
$3,574,468.00 
$3,574,468.00 
 
6
2020-09-09 
$0.00 
$5,584,950.00 
$5,584,950.00 
 
5
2019-08-27 
$0.00 
$3,982,750.00 
$3,982,750.00 
 
4
2017-09-13 
$3,691,000.00 
$3,691,000.00 
$0.00 
Equity 
3
2016-09-28 
$3,653,106.00 
$3,653,106.00 
$0.00 
 
2
2010-03-15 
$4,000,000.00 
$4,000,000.00 
$0.00 
Debt 
1
2010-02-04 
$2,300,000.00 
$2,500,000.00 
$200,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
BERMAN 
DIRECTOR
TIERONE CONVERGED NETWORKS INC   |  ADVAXIS, INC.   |  NEXMED INC   |  QUANTUMSPHERE INC   |  STRATEGIC FUNDING SOURCE, INC.   |  LUSTROS INC.   |  CATASYS, INC.   |  NEOSTEM, INC.   |  CRYOPORT, INC.   |  CALADRIUS BIOSCIENCES, INC.   |  TITAN ENVIRONMENTAL SOLUTIONS INC.   |  SIDUS SPACE INC.
CATHERINE 
 
BOVENIZER 
EXECUTIVE OFFICER
APRICUS BIOSCIENCES, INC.
EDWARD 
 
COX 
EXECUTIVE OFFICER
NEXMED INC   |  BQ KITS, INC.   |  EVERYSTORY, INC.   |  KNOWLEDGE MACHINE INTERNATIONAL, INC.   |  DTHERA SCIENCES
ROBERTO 
 
CREA 
DIRECTOR
NEXMED INC
MARGARET 
 
DALESANDRO 
DIRECTOR
SKYE BIOSCIENCE, INC.   |  SEELOS THERAPEUTICS, INC.
BASSAM 
B. 
DAMAJ 
DIRECTOR, EXECUTIVE OFFICER
NEXMED INC
BRIAN 
 
DORSEY 
EXECUTIVE OFFICER
MAGNASCI FUND L.P.   |  APRICUS BIOSCIENCES, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  SORRISO PHARMACEUTICALS, INC.   |  FORWARD SCIENCE HOLDING INC.
JUDITH 
 
DUNN 
DIRECTOR
SEELOS THERAPEUTICS, INC.   |  ELIEM THERAPEUTICS, INC.   |  AUSTIN COUNTY BANCSHARES   |  CLIMB BIO, INC.
HENRY 
J. 
ESBER 
DIRECTOR, EXECUTIVE OFFICER
NEXMED INC   |  OXYGEN THERAPY, INC.   |  BIOXYTRAN, INC
MICHAEL 
 
GOLEMBIEWSKI 
EXECUTIVE OFFICER
SEELOS THERAPEUTICS, INC.
BRIAN 
 
LIAN 
DIRECTOR
VIKING THERAPEUTICS, INC.   |  SEELOS THERAPEUTICS, INC.
VIVIAN 
 
LIU 
DIRECTOR, EXECUTIVE OFFICER
NEXMED INC   |  INNOVUS PHARMACEUTICALS, INC.   |  CESCA THERAPEUTICS INC.   |  THERMOGENESIS HOLDINGS, INC.
PAUL 
V. 
MAIER 
DIRECTOR
HANA BIOSCIENCES INC   |  PURE BIOSCIENCE   |  TALON THERAPEUTICS, INC.   |  APRICUS BIOSCIENCES, INC.   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  RITTER PHARMACEUTICALS INC
RAJ 
 
MEHRA 
EXECUTIVE OFFICER, DIRECTOR
SEELOS THERAPEUTICS, INC.   |  FREEDOM FINANCIAL HOLDINGS, INC.
NEIL 
 
MORTON 
EXECUTIVE OFFICER
APRICUS BIOSCIENCES, INC.
DANIEL 
J. 
O-CONNOR 
DIRECTOR
SEELOS THERAPEUTICS, INC.
LEONARD 
A 
OPPENHEIM 
DIRECTOR
NEXMED INC
LEONARD 
A. 
OPPENHEIM 
DIRECTOR
NEXMED INC   |  INPIXON
RICHARD 
W. 
PASCOE 
EXECUTIVE OFFICER, DIRECTOR
SOMAXON PHARMACEUTICALS, INC.   |  KEMPHARM, INC   |  APRICUS BIOSCIENCES, INC.   |  SEELOS THERAPEUTICS, INC.   |  HISTOGEN INC.
RUSTY 
 
RAY 
DIRECTOR
NEXMED INC   |  APRICUS BIOSCIENCES, INC.
ROBIN 
L. 
SMITH 
DIRECTOR
NEOSTEM, INC.   |  PROLUNG INC   |  SEELOS THERAPEUTICS, INC.   |  CELULARITY INC
SANDFORD 
D. 
SMITH 
DIRECTOR
NEURALSTEM, INC.   |  APRICUS BIOSCIENCES, INC.
MARK 
 
WESTGATE 
EXECUTIVE OFFICER
NEXMED INC   |  CESCA THERAPEUTICS INC.
WENDELL 
 
WIERENGA 
DIRECTOR
XENOPORT INC   |  CRINETICS PHARMACEUTICALS, INC.   |  APRICUS BIOSCIENCES, INC.   |  DERMATA THERAPEUTICS, LLC   |  DERMATA THERAPEUTICS, INC.
KLEANTHIS 
G. 
XANTHOPOULOS 
DIRECTOR
APRICUS BIOSCIENCES, INC.   |  SHORELINE BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-07-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2024-07-11 
2024-05-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2024-05-21 
2024-02-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2024-01-30 
2020-09-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2020-09-09 
2019-08-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2019-08-27 
2017-09-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-09-13 
2016-10-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2016-09-28 
2010-03-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2010-03-15 
2010-03-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2010-02-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
000000375
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
000015407
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
8361
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
15407
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
RODMAN + RENSHAW LLC
281264